Hood River Capital Management LLC Reata Pharmaceuticals Inc Transaction History

Hood River Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$78.27 - $151.29 $5.23 Million - $10.1 Million	-66,820 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$94.25 - $132.81 $583,784 - $822,625	-6,194 Reduced 8.48%	66,820 $6.66 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $135,087 - $244,436	1,324 Added 1.85%	73,014 $9.03 Million
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $674,351 - $1.18 Million	-7,210 Reduced 9.14%	71,690 $6.98 Million
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $9.97 Million - $13.9 Million	78,900 New	78,900 $12.3 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Hood River Capital Management LLC with notifications on news.